Home / Inspections / 1088827

FDA Inspection 1088827 — Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals Corporation — FEI 3010719477

The FDA completed an inspection of Biotest Pharmaceuticals Corporation on April 17, 2019 in Royal Palm Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 17, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Royal Palm Beach, FL (United States)

Facility

Other inspections at this facility

  • 1257057 (NAI Thu Nov 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1016494 (NAI Wed Feb 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources